Related Experiment Video
Updated: Jun 12, 2026
05:53
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
Risk categorization for complex disorders according to genotype relative risk and precision in parameter estimates
Graham H M Goddard1, Cathryn M Lewis
1Department of Medical and Molecular Genetics, King's College London, Guy's Hospital, London, UK.
Genetic Epidemiology
|June 23, 2010
Summary
Developing a genetic risk categorization method requires considering both variant risk and precision. This approach categorizes individuals based on confidence intervals compared to the average population risk.
Area of Science:
- Genetics
- Biostatistics
- Epidemiology
Background:
- Genetic variants play a role in disease susceptibility.
- Accurate genetic risk assessment is crucial for personalized medicine.
Purpose of the Study:
- To create a novel method for categorizing genetic disease risk.
- The method integrates the magnitude of genetic risk and its known precision.
Main Methods:
- Developed a risk assignment approach using population averages and empirical confidence intervals.
- Categorized individuals as higher or lower risk if their risk confidence interval did not overlap with the average.
- Applied the method to Crohn's disease and type 2 diabetes datasets.
Main Results:
- Population categorization depends on genotype relative risk, allele frequency, and study sample size.
- Low genotype relative risks or minor allele frequencies limit the ability to differentiate risk categories.
- The resolution into risk categories is influenced by parameter estimation accuracy.
Conclusions:
- The effectiveness of genetic risk variants for categorization hinges on relative risk magnitude and calculation accuracy.
- Accurate estimation of genetic relative risk and other risk factors is essential.
- Genetic risk assessments must incorporate an evaluation of the estimation's accuracy.
Related Concept Videos
01:28Human Genetics
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...